<DOC>
	<DOCNO>NCT01923142</DOCNO>
	<brief_summary>The purpose study evaluate hypothesis , patient stable vitiligo unresponsive conventional treatment include traditional phototherapy and/or topical steroid , application non-cultured autologous hair follicle outer-root-sheath melanocyte suspension area affect disease follow targeted ultraviolet B ( UVB ) phototherapy lead significant skin repigmentation . To assess effect propose treatment , within-subject control study involve select symmetric lesion area localize back hand conduct .</brief_summary>
	<brief_title>Efficacy Autologous Outer-Root-Sheath Melanocytes Transplantation Treatment Vitiligo</brief_title>
	<detailed_description />
	<mesh_term>Vitiligo</mesh_term>
	<criteria>Presence symmetric lesion vitiligo back hand extension &gt; 5cmÂ² Vitiligo last least one year back hand Stable vitiligo , define vitiligo present evident evolution ( appearance new lesion increase extension lesion already present ) least 6 month Suspension least two month prior enrollment date systemic drug vitiligo immunosuppressive treatment ( cyclosporine , systemic steroid ) psoralen + ultraviolet A therapy , phototherapy ultraviolet B , anticoagulant drug Suspension topical medication least 15 day prior enrollment date Presence active vitiligo Koebner phenomenon Difference 10 % extension symmetrical area vitiligo Presence systemic infection infection localize tissue intend transplantation History infection tissue intend transplantation ( herpes simplex , human papillomavirus infection , pityriasis versicolor , pityriasis alba ) Presence history malignancy Chemotherapy radiation therapy progress History allergies adverse reaction local anesthetic Presence transmissible disease ( human immunodeficiency virus , hepatitis B C , human Tlymphotropic virus type I II , syphilis , cytomegalovirus , CreutzfeldtJacob , tuberculosis ) Women pregnant intend become pregnant study period ( include breastfeed woman )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Vitiligo</keyword>
	<keyword>Outer-Root-Sheath</keyword>
	<keyword>Melanocytes</keyword>
	<keyword>Hair Follicles</keyword>
</DOC>